Galera Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2020 to Q4 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Galera Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q4 2024.
  • Galera Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 685 %, a 104% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 685 +350 +104% Dec 31, 2024
Q3 2024 576 +262 +83.6% Sep 30, 2024
Q2 2024 368 +22.1 +6.38% Jun 30, 2024
Q1 2024 331 -60.2 -15.4% Mar 31, 2024
Q4 2023 335 -99.2 -22.8% Dec 31, 2023
Q3 2023 314 -208 -39.9% Sep 30, 2023
Q2 2023 346 -228 -39.7% Jun 30, 2023
Q1 2023 392 -218 -35.8% Mar 31, 2023
Q4 2022 435 -125 -22.3% Dec 31, 2022
Q3 2022 522 -28.7 -5.2% Sep 30, 2022
Q2 2022 574 -26.1 -4.34% Jun 30, 2022
Q1 2022 610 -40.3 -6.2% Mar 31, 2022
Q4 2021 559 -256 -31.4% Dec 31, 2021
Q3 2021 551 -429 -43.8% Sep 30, 2021
Q2 2021 601 -365 -37.8% Jun 30, 2021
Q1 2021 650 Mar 31, 2021
Q4 2020 815 Dec 31, 2020
Q3 2020 980 Sep 30, 2020
Q2 2020 965 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.